Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.42 - $0.72 $178,010 - $305,161
423,835 New
423,835 $267,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $62,237 - $96,616
59,274 New
59,274 $66,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $46,078 - $209,294
24,252 New
24,252 $60,000
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $162,611 - $317,147
-11,062 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $244,121 - $337,411
-10,042 Reduced 47.58%
11,062 $314,000
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $210,468 - $325,906
-8,067 Reduced 27.65%
21,104 $712,000
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $708,079 - $1.22 Million
-21,418 Reduced 42.34%
29,171 $1.12 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $1.19 Million - $1.74 Million
30,382 Added 150.35%
50,589 $2.12 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $574,485 - $902,646
20,207 New
20,207 $876,000
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $824,424 - $2.97 Million
-107,909 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $590,240 - $808,339
-39,297 Reduced 26.7%
107,909 $1.74 Million
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $2.86 Million - $4.18 Million
-151,902 Reduced 50.79%
147,206 $2.84 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $3.65 Million - $5.53 Million
210,398 Added 237.18%
299,108 $7.03 Million
Q1 2019

May 14, 2019

BUY
$10.65 - $25.75 $415,083 - $1 Million
38,975 Added 78.37%
88,710 $2.08 Million
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $460,546 - $814,659
49,735 New
49,735 $550,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.